BIB Holdings Information

BIB is an equity ETF with a total of 263 individual holdings.

Total Holdings

263

Top 10 Percentage

152.36%

Asset Class

Equity

ETF Category

Trading--Leveraged Equity

Assets

77.46M

PE Ratio

n/a

Breakdown by Sector

No.	Symbol	Name	% Weight	Shares
1	n/a	NASDAQ BIO INDEX SWAP BNP PARIBAS	37.71%	4,820
2	n/a	NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NA	27.57%	3,524
3	n/a	NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NA	26.40%	3,374
4	n/a	NASDAQ BIOTECHNOLOGY INDEX SWAP GOLDMAN SACHS INTERNATIONAL	20.65%	2,639
5	n/a	NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALE	17.22%	2,201
6	n/a	NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG	4.95%	633
7	GILD	Gilead Sciences, Inc.	4.79%	27,203
8	VRTX	Vertex Pharmaceuticals Incorporated	4.68%	8,153
9	AMGN	Amgen Inc.	4.54%	10,439
10	REGN	Regeneron Pharmaceuticals, Inc.	3.85%	4,089
11	ALNY	Alnylam Pharmaceuticals, Inc.	1.96%	5,220
12	BIIB	Biogen Inc.	1.51%	5,775
13	RVMD	Revolution Medicines, Inc.	1.48%	7,801
14	UTHR	United Therapeutics Corporation	1.30%	1,725
15	ARGX	argenx SE	1.20%	1,117
16	INSM	Insmed Incorporated	1.16%	8,487
17	RPRX	Royalty Pharma plc	1.15%	16,866
18	ILMN	Illumina, Inc.	1.13%	6,020
19	MRNA	Moderna, Inc.	1.08%	15,547
20	ROIV	Roivant Sciences Ltd.	1.08%	28,182
21	INCY	Incyte Corporation	1.04%	7,838
22	VTRS	Viatris Inc.	1.01%	45,333
23	NBIX	Neurocrine Biosciences, Inc.	0.79%	3,952
24	ASND	Ascendis Pharma A/S	0.76%	2,423
25	SMMT	Summit Therapeutics Inc.	0.75%	30,528

Showing 25 of 263 holdings

Subscribe to see the full list

As of May 11, 2026